Carbon Monoxide Poisoning Clinical Trial
Official title:
Comparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications: A Prospective, Observational Study
NCT number | NCT06198595 |
Other study ID # | E2-23-5424 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | December 20, 2023 |
Est. completion date | June 30, 2024 |
Carbon monoxide (CO) poisoning is a condition that occurs as a result of inhaling carbon monoxide gas and can potentially lead to serious health issues. The treatment of CO poisoning requires urgent medical intervention. Methods used in the treatment of CO poisoning include normobaric oxygen (oxygen at normal pressure), high-flow oxygen, non-invasive continuous positive airway pressure (CPAP), and hyperbaric oxygen therapy. Studies on these methods are available in the literature.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | June 30, 2024 |
Est. primary completion date | May 20, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Between the ages of 18 and 65, - Without any underlying health conditions, - Diagnosed with carbon monoxide poisoning, - Capable of providing consent either personally or through a legal representative. Exclusion Criteria: - Under the age of 18, - Over the age of 65, - With underlying health conditions, - Without a diagnosis of carbon monoxide poisoning, - Patients who do not wish to share their data. |
Country | Name | City | State |
---|---|---|---|
Turkey | Ankara Bilkent Sehir Hastanesi | Ankara | Çankaya |
Lead Sponsor | Collaborator |
---|---|
Ankara City Hospital Bilkent |
Turkey,
Akkan S, Uyanik O. Comparing high-flow nasal oxygen therapy and normobaric oxygen therapy on the treatment of carbon monoxide poisoning. Med Klin Intensivmed Notfmed. 2023 Aug 2. doi: 10.1007/s00063-023-01044-5. Online ahead of print. — View Citation
Caglar B, Serin S, Yilmaz G, Torun A, Parlak I. The Impact of Treatment with Continuous Positive Airway Pressure on Acute Carbon Monoxide Poisoning. Prehosp Disaster Med. 2019 Dec;34(6):588-591. doi: 10.1017/S1049023X19005028. Epub 2019 Oct 22. — View Citation
Kim YM, Shin HJ, Choi DW, Kim JM, Lee SW, Jeong SH, Kim H. Comparison of high-flow nasal cannula oxygen therapy and conventional reserve-bag oxygen therapy in carbon monoxide intoxication: A pilot study. Am J Emerg Med. 2020 Aug;38(8):1621-1626. doi: 10.1016/j.ajem.2019.158451. Epub 2019 Nov 6. — View Citation
Ozturan IU, Yaka E, Suner S, Ozbek AE, Alyesil C, Dogan NO, Yilmaz S, Pekdemir M. Determination of carboxyhemoglobin half-life in patients with carbon monoxide toxicity treated with high flow nasal cannula oxygen therapy. Clin Toxicol (Phila). 2019 Jul;57(7):617-623. doi: 10.1080/15563650.2018.1540046. Epub 2019 Jan 28. — View Citation
Roth D, Mayer J, Schreiber W, Herkner H, Laggner AN. Acute carbon monoxide poisoning treatment by non-invasive CPAP-ventilation, and by reservoir face mask: Two simultaneous cases. Am J Emerg Med. 2018 Sep;36(9):1718.e5-1718.e6. doi: 10.1016/j.ajem.2018.05.066. Epub 2018 May 29. — View Citation
Turgut K, Yavuz E. CPAP versus HFNC use in carbon monoxide poisoning. Am J Emerg Med. 2021 Aug;46:727. doi: 10.1016/j.ajem.2020.09.085. Epub 2020 Oct 2. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Carboxyhemoglobin | Blood carboxyhemoglobin saturation is typically expressed as a percentage. For example, the statement "blood carboxyhemoglobin saturation is 5%" indicates that 5% of hemoglobin has been converted to carboxyhemoglobin. This ratio affects the oxygen-carrying capacity of the blood and serves as an indicator of carbon monoxide poisoning. After treatment, a decrease in this ratio signifies the elimination of carbon monoxide from the body and the restoration of normal oxygen-carrying function. | 6 hours later | |
Primary | lactate | Blood lactate levels are typically measured in millimoles per liter (mmol/L) | 6 hours later |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03669848 -
Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?
|
||
Completed |
NCT04656912 -
Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
|
||
Recruiting |
NCT04975867 -
Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning
|
N/A | |
Terminated |
NCT01099995 -
Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning
|
Phase 3 | |
Terminated |
NCT01100515 -
Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning
|
Phase 3 | |
Terminated |
NCT03017742 -
Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
|
||
Terminated |
NCT01059708 -
Outcome Following Carbon Monoxide Poisoning in Children
|
N/A | |
Recruiting |
NCT05591300 -
Microparticles Blood Level in Acute Carbon Monoxide Poisoning
|
||
Not yet recruiting |
NCT04475263 -
Cognitive and Blood Biomarker Assessment After CO Exposure
|
||
Completed |
NCT03926494 -
Carbon Monoxide-induced Coma: Prognostic Factors
|
||
Recruiting |
NCT02375126 -
Normal Quantitative EEG (qEEG) Dataset
|
||
Completed |
NCT03342209 -
Utility of High Flow Nasal Cannula in CO Toxicity
|
N/A | |
Completed |
NCT00465855 -
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
|
Phase 4 | |
Recruiting |
NCT04490317 -
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
|
||
Withdrawn |
NCT04118491 -
Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy
|
N/A | |
Unknown status |
NCT00841165 -
Carbon Monoxide Monitoring and Emergency Treatment
|
N/A | |
Withdrawn |
NCT00280579 -
Cyanide Poisoning in Fire Victims
|
N/A | |
Enrolling by invitation |
NCT02483650 -
Hyperbaric Oxygen Therapy Registry
|
||
Completed |
NCT05088005 -
Prognostic Biomarkers in CO Poisoning
|
||
Completed |
NCT03030833 -
Dysfunctional Hemoglobin Pulse Oximetry
|
N/A |